APOTEL 1000mg i.v. Paracetamol

Product Technical Specification

• Finished Dosage Form: Solution for infusion 150mg/ml filled in 1g/ 6.7ml type I glass ampoules (primary packaging)
• Packaging: BTx3 in a PVC/ALU blister placed in a carton box
• Administration: Ampoule concentrate is diluted in the content of 100ml 0.9% NaCl solution, mixed & infused slowly over a period of 15min

Efficacy Profile

• First line therapy for pain relief and fever management in post-operative patients
• Rapid pain relief and fever management³
  • First pain relief 5-10 min post administration
  • Maximum analgesic effect within 1 hour
  • Decreases fever within 30 min post administration
  • Analgesic & antipyretic effect lasts up to 6 hrs
• First line therapy in the treatment of childhood fever^5,6
• Decreases the required dose of centrally acting agents (morphine, pethidine) in severe pain ¹ when administered concomitantly
  • 33% Reduction in morphine administration requirements, over a 24hr period in post-operative, orthopaedic patients³

Safety Profile

• 25 years of clinical experience
• Excellent Pharmacovigilance record: No Adverse Events reported
• No inhibitory effect on platelet aggregation³.
  • Can be administered to patients with neutropenia and thrombocytopenia
• Not an NSAID: Free of all related SAEs of the category³
  • Can be administered to patients with active, or history of GI ulcer
  • Very rare incidence of hypersensitivity reactions
  • Does not precipitate bronco-spasm
  • Low impact on renal function

Dosage